Medical Equipment ManufacturingCalifornia, United States501-1000 Employees
CERENOVUS, part of Johnson & Johnson MedTech, is an emerging leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke.
| CERENOVUS Email Formats | Percentage |
| FLast@its.jnj.com | 62% |
| LFirst@its.jnj.com | 6% |
| First.Last@its.jnj.com | 5% |
| F-Last@its.jnj.com | 3% |
| FirstLast@its.jnj.com | 2% |
| FiLast@its.jnj.com | 1% |
| LastFir@its.jnj.com | 2% |
| LastFirst@its.jnj.com | 1% |
| First_Last@its.jnj.com | 1% |
| First-Last@its.jnj.com | 2% |
| Last.First@its.jnj.com | 1% |
| FirLast@its.jnj.com | 1% |
| Last_First@its.jnj.com | 1% |
| LastF@its.jnj.com | 2% |
| LastFi@its.jnj.com | 1% |
| FirstL@its.jnj.com | 1% |
| F.Last@its.jnj.com | 1% |
| F_Last@its.jnj.com | 1% |
| FirstLa@its.jnj.com | 1% |
| FMLast@its.jnj.com | 1% |
| First.L@its.jnj.com | 1% |
| FL@its.jnj.com | 1% |
| FirstMiddleLas@its.jnj.com | 1% |
| LF@its.jnj.com | 1% |
| First.Last@jnj.com | 70% |
| FLast@jnj.com | 19% |
| Last@jnj.com | 6% |
| First@jnj.com | 5% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com